バイオインフォマティクス：技術と世界市場

世界のバイオインフォマティクス市場は2025年に235億ドル規模となり、2025年から2030年にかけて年平均成長率（CAGR）13.1%で推移し、2030年末までに435億ドルに達するとBCC Researchでは予測しています。

BCC Research（BCCリサーチ）「バイオインフォマティクス：技術と世界市場 – Bioinformatics: Technologies and Global Markets」はバイオインフォマティクスの世界市場を調査し、主要セグメント別に分析・予測を行っています。

調査対象セグメント

• ソリューション
  • ハードウェア
  • ソフトウェア
  • サービス
• シーケンスサービス＆プラットフォーム
  • シーケンスサービス
  • シーケンスプラットフォーム
• 展開
  • オンプレミス
  • クラウド
• 用途
  • ゲノミクス
  • プロテオミクス
  • トランスクリプトミクス
  • ファーマコゲノミクス
  • メタボロミクス
  • ケモインフォマティクス
  • メタゲノミクス
• エンドユーザ
  • 製薬会社とバイオテクノロジー企業
  • 学術研究機関
• 地域
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • スペイン
    • スイス
    • デンマーク
    • ノルウェー
    • ポーランド
    • ベルギー
    • オーストリア
    • オランダ
    • スウェーデン
    • ロシア
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • ニュージーランド
    • 台湾
    • シンガポール
    • マレーシア
    • タイ
    • フィリピン
    • インドネシア
  • 南米
    • ブラジル
    • アルゼンチン
    • ペルー
    • コロンビア
  • 中東＆アフリカ
    • 南アフリカ
    • イスラエル
    • アラブ首長国連邦（UAE）
    • エジプト
    • トルコ
    • イラン
    • イラク

レポートの主な内容

• 68のデータ表および63の追加表
• バイオインフォマティクス技術の世界市場に関する詳細な分析
• 世界市場の動向分析（2022～2024年の実績データ、2025年の推定値、および2030年までの年平均成長率（CAGR）の予測を含む）
• 現在の市場規模の推定および収益予測、ならびにソリューション、シーケンシングサービス・プラットフォーム、導入形態、用途、エンドユーザー、地域別の市場シェア分析
• 市場のダイナミクス、技術の進歩、規制、将来展望、およびマクロ経済的要因の影響に関する事実とデータ
• ポーターの「ファイブフォース（5つの力）」モデルに基づく考察および世界的なサプライチェーン分析
• 主要な登録特許および公開特許の概観
• 業界構造の分析（企業のシェアや世界ランキング、戦略的取り組み、M&A動向、ベンチャー資金調達の見通しなど）
• サステナビリティのトレンドとESG（環境・社会・ガバナンス）関連の動向の概要（消費者の意識、主要企業のESGリスク評価および取り組みに重点を置く）
• 業界の主要企業（Illumina Inc.、Thermo Fisher Scientific Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、PacBioなど）の企業概要

Report Highlights

The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.

Report Includes

• 68 data tables and 63 additional tables
• In-depth analysis of the global market for bioinformatics technologies
• Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
• Estimates of the current market size and revenue forecasts, accompanied by a corresponding market share analysis based on based on solution, sequencing services and platforms, deployment type, application, end-use, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, prospects, and the impact of macroeconomic variables
• Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
• Review of key granted and published patents
• Analysis of the industry structure, including companies’ shares and global rankings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Company profiles of major players within the industry, including Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., and PacBio

Report Scope

The report provides an overview of the global bioinformatics market and analyzes market trends. The report includes global revenue ($ million) for the base year, 2024, and estimated revenue for the forecast period, 2025 through 2030. The market is segmented by solution, sequencing services and platforms, deployment, application, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, and the rest of the world, with a focus on major countries in each region.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It discusses emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key companies in the global bioinformatics market. It also has a dedicated section of company profiles that covers details such as overviews, key financials, product portfolios, recent developments of key market companies, and patent analysis.

Table of Contents

Chapter 1 Executive Summary

Market Outlook
Scope of the Report
Market Summary
Market Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Introduction
Current and Future Market Overview
Technology Background
Biological Data Sources
Bioinformatics in Systems Biology
Bioinformatics in Precision Medicine
Bioinformatics in Drug Development
Next-Generation Sequencing
Bioinformatics in Metagenomics
Bioinformatics in Database Management Systems
PESTEL Analysis
Impact of U.S. Tariff Laws on the Global Bioinformatics Market
Porter’s Five Forces Analysis
Bargaining Power of Buyers: Moderate to High
Bargaining Power of Suppliers: Moderate to High
Threat of Substitute: Moderate
Threat of New Entrants: Moderate
Industry Rivalry: High
Supply Chain Analysis
Upstream: Data Generation and Raw Inputs
Technology Infrastructure and Platform Development
Data Processing, Analysis, and Interpretation
Midstream Integration and Validation
Downstream: Commercialization and End Users
Support Services and Ecosystem Partners
Key Supply Chain Risks and Constraints
Supply Chain Optimization Trends
Value Chain Analysis
Inbound Activities: Data and Input Acquisition
Operations: Platform and Algorithm Development
Data Processing and Analytical Services
Integration, Validation, and Interpretation
Marketing, Sales, and Commercialization
Service, Support, and Continuous Improvement

Chapter 3 Market Dynamics

Overview
Market Drivers
Exponential Growth in Biological and Genomic Data
Expansion of Personalized and Precision Medicine
Integration of AI, Machine Learning, and Advanced Analytics
Cloud Computing and Scalable Platforms
Growing Demand for Drug Discovery and Development Tools
Market Restraints
Data Privacy and Security Concerns
Issues Regarding Modeling Systems
High Costs of Implementation and Maintenance
Market Opportunities
Market Expansion into Emerging Countries
Growth in Next-Generation Sequencing (NGS) and High-Throughput Analysis

Chapter 4 Regulatory Landscape

Overview
Regulatory Frameworks, by Select Country/Region
U.S.
Europe
Asia-Pacific
Rest of the World

Chapter 5 Emerging Technologies and New Developments

Emerging Technologies/Trends
Artificial Intelligence (AI) and Machine Learning (ML) Integration
Cloud Computing and Big Data Infrastructure
High-Throughput and Advanced Sequencing Technologies
Multi-Omics and Single-Cell Analytics
Gene Editing Informatics
Spatial Transcriptomics and Imaging Integration

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown

Market Breakdown, by Solution

Key Takeaways
Hardware
Software
Services

Market Breakdown, by Sequencing Services and Platforms

Key Takeaways
Sequencing Services
Sequencing Platforms

Market Breakdown, by Deployment

Key Takeaways
On-Premises
Cloud-Based

Market Breakdown, by Application

Key Takeaways
Genomics
Proteomics
Transcriptomics
Pharmacogenomics
Metabolomics
Cheminformatics
Metagenomics
Others

Market Breakdown, by End User

Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others

Geographic Breakdown
Market Breakdown, by Region

Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Chapter 7 Competitive Intelligence

Key Takeaways
Top Companies Ranking, 2024
Strategic Analysis
Chapter 8 Appendix
Methodology
Abbreviations
References

Company Profiles

AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
DASSAULT SYSTEMES
DNASTAR
EXCELRA
ILLUMINA INC.
MACVECTOR INC.
MOLECULAR NETWORKS GMBH
OCIMUM BIOSOLUTIONS
PACBIO
QLUCORE AB
REAL TIME GENOMICS
REVVITY
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.

Emerging Start-Ups

List of Tables

Summary Table : Global Market for Bioinformatics, by Region, Through 2030
Table 1 : Bioinformatics Tools Used for Metagenomics Analysis
Table 2 : Asia-Pacific Bioinformatics Market: Regulatory Landscape
Table 3 : RoW Bioinformatics Market: Regulatory Landscape
Table 4 : Global Market for Bioinformatics, by Solution, Through 2030
Table 5 : Global Market for Bioinformatics Hardware, by Type, Through 2030
Table 6 : Global Market for Bioinformatics Hardware, by Region, Through 2030
Table 7 : High-Performance Computing Architectures: Advantages and Drawbacks
Table 8 : Highest Performance Supercomputers, 2025
Table 9 : List of SaaS Products for Data Analysis in Bioinformatics
Table 10 : Global Market for High-Performance Computing Clusters in Bioinformatics Hardware, by Region, Through 2030
Table 11 : Global Market for Storage Systems in Bioinformatics Hardware, by Region, Through 2030
Table 12 : Global Market for Bioinformatics Servers in Bioinformatics Hardware, by Region, Through 2030
Table 13 : Global Market for Bioinformatics Appliances in Bioinformatics Hardware, by Region, Through 2030
Table 14 : Global Market for Bioinformatics in Other Hardware Solutions, by Region, Through 2030
Table 15 : Global Market for Bioinformatics Software, by Region, Through 2030
Table 16 : Global Market for Bioinformatics Services, by Region, Through 2030
Table 17 : Global Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
Table 18 : List of Bioinformatics Sequence Analysis Software
Table 19 : Global Market for Bioinformatics Sequencing Services, by Region, Through 2030
Table 20 : List of Bioinformatics Sequence Alignment Platforms
Table 21 : Global Market for Bioinformatics Sequencing Platforms, by Region, Through 2030
Table 22 : Global Market for Bioinformatics, by Deployment, Through 2030
Table 23 : Global Market for Bioinformatics On-Premises Deployment, by Region, Through 2030
Table 24 : Cloud-Based Bioinformatics Tools
Table 25 : Global Market for Bioinformatics Cloud-Based Deployment, by Region, Through 2030
Table 26 : Global Market for Bioinformatics, by Application, Through 2030
Table 27 : Global Market for Bioinformatics in Genomics Applications, by Region, Through 2030
Table 28 : Global Market for Bioinformatics in Proteomics Applications, by Region, Through 2030
Table 29 : Global Market for Bioinformatics in Transcriptomics Applications, by Region, Through 2030
Table 30 : Pharmacogenomic Biomarkers in Drug Labeling
Table 31 : Bioinformatics Tools and Databases Used in Pharmacogenomics
Table 32 : Bioinformatics Tools for Pharmacogenomic Studies
Table 33 : Global Market for Bioinformatics in Pharmacogenomics Applications, by Region, Through 2030
Table 34 : Commercially Available Metabolomics Software
Table 35 : Open Access Tools for Complex Liquid Chromatography-Mass SpectrometryData Analysis
Table 36 : Global Market for Bioinformatics in Metabolomics Applications, by Region, Through 2030
Table 37 : Cheminformatics Software Solutions for Drug R&D
Table 38 : Global Market for Bioinformatics in Cheminformatics Applications, by Region, Through 2030
Table 39 : Global Market for Bioinformatics in Metagenomics Applications, by Region, Through 2030
Table 40 : Global Market for Bioinformatics in Other Applications, by Region, Through 2030
Table 41 : Global Market for Bioinformatics, by End User, Through 2030
Table 42 : Global Market for Bioinformatics for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
Table 43 : Global Market for Bioinformatics for Academic and Research Institutes, by Region, Through 2030
Table 44 : Global Market for Bioinformatics for Other End Users, by Region, Through 2030
Table 45 : Global Market for Bioinformatics, by Region, Through 2030
Table 46 : Number of Grants, by Type of Cancer, October 2025
Table 47 : North American Market for Bioinformatics, by Solution, Through 2030
Table 48 : North American Market for Bioinformatics, by Hardware Type, Through 2030
Table 49 : North American Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
Table 50 : North American Market for Bioinformatics, by Deployment, Through 2030
Table 51 : North American Market for Bioinformatics, by Application, Through 2030
Table 52 : North American Market for Bioinformatics, by End User, Through 2030
Table 53 : North American Market for Bioinformatics, by Country, Through 2030
Table 54 : Leading Bioinformatics Companies in the U.S.
Table 55 : Projected Cancer-Related Deaths in Males in Canada, by Cancer Type, 2025
Table 56 : Projected Cancer-Related Deaths in Females in Canada, by Cancer Type, 2025
Table 57 : Leading European Bioinformatics Companies
Table 58 : European Market for Bioinformatics, by Solution, Through 2030
Table 59 : European Market for Bioinformatics, by Hardware Type, Through 2030
Table 60 : European Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
Table 61 : European Market for Bioinformatics, by Deployment, Through 2030
Table 62 : European Market for Bioinformatics, by Application, Through 2030
Table 63 : European Market for Bioinformatics, by End User, Through 2030
Table 64 : European Market for Bioinformatics, by Country, Through 2030
Table 65 : Asia-Pacific Market for Bioinformatics, by Solution, Through 2030
Table 66 : Asia-Pacific Market for Bioinformatics, by Hardware Type, Through 2030
Table 67 : Asia-Pacific Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
Table 68 : Asia-Pacific Market for Bioinformatics, by Deployment, Through 2030
Table 69 : Asia-Pacific Market for Bioinformatics, by Application, Through 2030
Table 70 : Asia-Pacific Market for Bioinformatics, by End User, Through 2030
Table 71 : Asia-Pacific Market for Bioinformatics, by Country, Through 2030
Table 72 : RoW Market for Bioinformatics, by Solution, Through 2030
Table 73 : RoW Market for Bioinformatics, by Hardware Type, Through 2030
Table 74 : RoW Market for Bioinformatics, by Sequencing Services and Platforms, Through 2030
Table 75 : RoW Market for Bioinformatics, by Deployment, Through 2030
Table 76 : RoW Market for Bioinformatics, by Application, Through 2030
Table 77 : RoW Market for Bioinformatics, by End User, Through 2030
Table 78 : RoW Market for Bioinformatics, by Sub-Region, Through 2030
Table 79 : Top Companies Ranking, 2024
Table 80 : Recent Developments in the Global Bioinformatics Market, 2023–2026
Table 81 : Abbreviations Used in this Report
Table 82 : Agilent Technologies Inc.: Company Snapshot
Table 83 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 84 : Agilent Technologies Inc.: Product Portfolio
Table 85 : Agilent Technologies Inc.: News/Key Developments, 2023–2025
Table 86 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 87 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 88 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 89 : Dassault Systèmes: Company Snapshot
Table 90 : Dassault Systèmes: Financial Performance, FY 2023 and 2024
Table 91 : Dassault Systèmes: Product Portfolio
Table 92 : Dassault Systèmes: News/Key Developments, 2024
Table 93 : DNASTAR: Company Snapshot
Table 94 : DNASTAR: Product Portfolio
Table 95 : DNASTAR: News/Key Developments, 2025
Table 96 : Excelra: Company Snapshot
Table 97 : Excelra: Product Portfolio
Table 98 : Illumina Inc.: Company Snapshot
Table 99 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 100 : Illumina Inc.: Product Portfolio
Table 101 : Illumina Inc.: News/Key Developments, 2024–2026
Table 102 : MacVector Inc.: Company Snapshot
Table 103 : MacVector Inc.: Product Portfolio
Table 104 : Molecular Networks GmbH: Company Snapshot
Table 105 : Molecular Networks GmbH: Product Portfolio
Table 106 : Molecular Networks GmbH: News/Key Developments, 2025
Table 107 : Ocimum Biosolutions: Company Snapshot
Table 108 : Ocimum Biosolutions: Product Portfolio
Table 109 : PacBio: Company Snapshot
Table 110 : PacBio: Financial Performance, FY 2023 and 2024
Table 111 : PacBio: Product Portfolio
Table 112 : PacBio: News/Key Developments, 2025
Table 113 : Qlucore AB: Company Snapshot
Table 114 : Qlucore AB: Financial Performance, FY 2023 and 2024
Table 115 : Qlucore AB: Product Portfolio
Table 116 : Qlucore AB: News/Key Developments, 2025
Table 117 : Real Time Genomics: Company Snapshot
Table 118 : Real Time Genomics: Product Portfolio
Table 119 : Revvity: Company Snapshot
Table 120 : Revvity: Financial Performance, FY 2023 and 2024
Table 121 : Revvity: Product Portfolio
Table 122 : Siemens Healthineers AG: Company Snapshot
Table 123 : Siemens Healthineers AG: Financial Performance, FY 2024 and 2025
Table 124 : Siemens Healthineers AG: Product Portfolio
Table 125 : Siemens Healthineers AG: News/Key Developments, 2025
Table 126 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 127 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 128 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 129 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
Table 130 : Emerging Startups in the Global Bioinformatics Market

List of Figures

Summary Figure : Summary Figure: Global Market Share for Bioinformatics, by Region, 2024
Figure 1 : Bioinformatics Relationship with Omic Technologies
Figure 2 : Applications of Bioinformatics in Drug Development
Figure 3 : PESTEL Analysis: Bioinformatics Market
Figure 4 : Porter’s Five Forces Analysis: Bioinformatics Market
Figure 5 : Supply Chain Analysis: Global Bioinformatics Market
Figure 6 : Value Chain Analysis: Global Bioinformatics Market
Figure 7 : Market Dynamics of Bioinformatics
Figure 8 : Emerging Technologies in the Bioinformatics Market
Figure 9 : Global Market Share for Bioinformatics, by Solution, 2024
Figure 10 : Global Market Share for Bioinformatics, by Sequencing Services and Sequencing Platforms, 2024
Figure 11 : Global Market Share for Bioinformatics, by Deployment, 2024
Figure 12 : Global Market Share for Bioinformatics, by Application, 2024
Figure 13 : Global Market Share for Bioinformatics, by End User, 2024
Figure 14 : Global Market Share for Bioinformatics, by Region, 2024
Figure 15 : North American Market Share for Bioinformatics, by Country, 2024
Figure 16 : European Market Share for Bioinformatics, by Country, 2024
Figure 17 : Asia-Pacific Market Share for Bioinformatics, by Country, 2024
Figure 18 : RoW Market Share for Bioinformatics, by Sub-Region, 2024
Figure 19 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
Figure 20 : Agilent Technologies Inc.: Revenue Share, by Region/Country, FY 2024
Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Region/Country, FY 2024
Figure 23 : Dassault Systèmes: Revenue Share, by Business Unit, FY 2024
Figure 24 : Dassault Systèmes: Revenue Share, by Region/Country, FY 2024
Figure 25 : Illumina Inc.: Revenue Share, by Business Unit, FY 2024
Figure 26 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
Figure 27 : PacBio: Revenue Share, by Region/Country, FY 2024
Figure 28 : Revvity: Revenue Share, by Business Unit, FY 2024
Figure 29 : Revvity: Revenue Share, by Region/Country, FY 2024
Figure 30 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2025
Figure 31 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2025
Figure 32 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024

---

---